Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Randstad on its takeover bid for Proffice
Mandate

Vinge advises Randstad on its takeover bid for Proffice

November 30, 2015

Randstad Nordic AB, a company owned by Randstad Holding nv (NYSE Euronext Amsterdam), has announced a recommended cash offer to the shareholders of Proffice AB (publ) (Nasdaq Stockholm). The total offer value for the outstanding shares in Proffice amounts to SEK 1,648 million.
 
Vinge advises the bidder. The Vinge team is headed by capital markets and public M&A partner Erik Sjöman. Other team members include Anna Edström, Jo-Anna Nordström, Mattias Sköld, Malte Hedlund and Susanne Samuelsson as well as Pär Remnelid and Ina Lunneryd (competition law) and Fredrik Dahl and Sara Strandberg (employment law).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026